Cardiome Pharma Corporation Gross Margin 2016-2019 | CORV
Current and historical gross margin for Cardiome Pharma Corporation (CORV) over the last 10 years. The current gross profit margin for Cardiome Pharma Corporation as of September 30, 2019 is %.
| Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2019-09-30 | $0.03B | $0.02B | 70.00% |
| 2019-06-30 | $0.03B | $0.02B | 73.33% |
| 2019-03-31 | $0.03B | $0.02B | 72.41% |
| 2018-12-31 | $0.03B | $0.02B | 68.97% |
| 2018-09-30 | $0.03B | $0.02B | 66.67% |
| 2018-06-30 | $0.03B | $0.02B | 69.23% |
| 2018-03-31 | $0.03B | $0.02B | 69.23% |
| 2017-12-31 | $0.02B | $0.02B | 75.00% |
| 2017-09-30 | $0.02B | $0.02B | 75.00% |
| 2017-06-30 | $0.02B | $0.02B | 73.91% |
| 2017-03-31 | $0.02B | $0.02B | 73.91% |
| 2016-12-31 | $0.03B | $0.02B | 76.00% |
| 2016-09-30 | $0.02B | $0.02B | 69.57% |
| 2016-06-30 | $0.02B | $0.02B | 69.57% |
| 2016-03-31 | $0.02B | $0.02B | 73.91% |
| 2015-12-31 | $0.02B | $0.02B | 71.43% |
